In addition, HHS Secretary Robert F. Kennedy Jr. addressed the delay in Novavax's approval in a CBS interview earlier this ...

The UK’s Voluntary Scheme for Branded Medicines Pricing and Access ( VPAG) was agreed upon by the ABPI, the research-based ...

Valneva said it has been supplying Ixchiq to help the French government respond to a major outbreak of chikungunya in La ...

Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular ...

AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

Anyone who purports to care about global health, about public health, should be speaking out against these actions, loudly ...

The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the ...

A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland. The MAGIC-I (Molecular and Genomic Interrogation of ...

Lawyers for Todd Engel, 62, filed suit yesterday in New Jersey superior court. According to the complaint, Engel is now ...